The Cerebral Vasospasm Market is expanding as healthcare providers seek improved diagnostic and therapeutic solutions for cerebral vasospasm, a serious complication that can occur following subarachnoid hemorrhage. Market Research Future estimates that the market was valued at USD 2.41 billion in 2024 and is projected to reach USD 4.74 billion by 2035, registering a CAGR of 6.35% during 2025–2035.
Cerebral vasospasm can restrict blood flow to the brain and increase the risk of neurological complications. Growing awareness of the condition, advances in neurovascular imaging, and increasing investment in neuroscience research are supporting demand for improved diagnosis and treatment.
The market is also benefiting from innovations in minimally invasive interventions and pharmaceutical therapies. As healthcare systems focus on earlier detection and improved outcomes, demand for advanced neurovascular technologies is expected to increase.
